AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |
| Artia Global Partners LP | 87,848 | $6,139,697 | 2.55% |
| Ghost Tree Capital, LLC | 110,000 | $7,687,900 | 2.53% |
| Nicholas Investment Partners, LP | 394,980 | $27,605,152 | 2.06% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 145,033 | $10,136,356 | 2.05% |
| HighVista Strategies LLC | 56,964 | $3,981,214 | 1.84% |
| MPM BioImpact LLC | 93,586 | $6,540,726 | 1.75% |
| PFM Health Sciences, LP | 523,210 | $36,567,147 | 1.72% |
| Soleus Capital Management, L.P. | 237,500 | $16,598,875 | 1.53% |
| Privium Fund Management B.V. | 72,032 | $5,034,316 | 1.50% |
| Boxer Capital, LLC | 400,000 | $27,956,000 | 1.49% |
External links
This page lists AXSOME THERAPEUTICS INC's shareholders in Q3 2023. To view AXSOME THERAPEUTICS INC's shareholder history, click here.